BlackRock Japan’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16K Buy
2,880
+2,043
+244% +$14.4K ﹤0.01% 1167
2016
Q3
$6K Buy
+837
New +$6.12K ﹤0.01% 1250
2016
Q1
Sell
-425
Closed -$9K 1564
2015
Q4
$9K Sell
425
-489
-54% -$8.43K ﹤0.01% 1287
2015
Q3
$11K Hold
914
﹤0.01% 1163
2015
Q2
$19K Sell
914
-712
-44% -$16.8K ﹤0.01% 1212
2015
Q1
$34K Buy
1,626
+581
+56% +$15.2K ﹤0.01% 1130
2014
Q4
$32K Buy
+1,045
New +$29K ﹤0.01% 1162

Other funds holding IMDZ

BlackRock Japan's IMDZ Position: Q4 2016 in Review

BlackRock Japan increased its Immune Design Corp. (IMDZ) stake by 244% in Q4 2016, buying an estimated $14.4K and bringing the position to 2,880 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

BlackRock Japan first reported a position in IMDZ in Q4 2014 and has held it in 7 quarters since. The position peaked at $34K in Q1 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

  • BlackRock Japan held 2,880 shares of Immune Design Corp. worth $16K as of Q4 2016.
  • BlackRock Japan bought 2,043 Immune Design Corp. shares in Q4 2016, an estimated $14.4K.
  • Immune Design Corp. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1167 holding.
  • BlackRock Japan first reported a position in Immune Design Corp. in Q4 2014 and has held it in 7 quarters since.
  • BlackRock Japan's Immune Design Corp. position peaked at $34K in Q1 2015.
  • 65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.